Stock Forecast

  ShockWave Medical, Inc. ( SWAV) Stock. Should you Buy or Sell?    $ 287.14

-6.06 (-2.16 %)



ShockWave Medical, Inc. Analysis

Updated on 10-09-2022
Symbol SWAV
Price $287.14
Beta 1.235
Volume Avg. $618.66 thousand
Market Cap $10.32 B
52 Week Range $113.36 - $314.9


ShockWave Medical, Inc. opened the day at $287.14 which is -2.16 % on yesterday's close. ShockWave Medical, Inc. has a 52 week high of $314.9 and 52 week low of $113.36, which is a difference of $201.54. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $10.32 B and total net profit is $237146000 which means the company is trading at 43.50 times profit to market capitalization. Theoretically, if you were to buy ShockWave Medical, Inc. for $10.32 B, it would take 15 years to get your money back. ShockWave Medical, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




ShockWave Medical, Inc. Stock Forecast - Is ShockWave Medical, Inc. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationBuy

Growth and Value


PE Ratio 191.427
Dividend Yiel 0.000
Net Profit Margin 0.151


Valuing ShockWave Medical, Inc.


Price Book Value Ratio 33.721 Price To Book Ratio 33.721
Price To Sales Ratio 28.283 Price Earnings Ratio 187.133


How liquid is ShockWave Medical, Inc.


Current Ratio 5.317
Quick Ratio 4.300


Debt


Debt Ratio 0.269 Debt Equity Ratio 0.367
Long Term Debt To Capitalization 0.099 Total Debt To Capitalization 0.134



Latest news about ShockWave Medical, Inc.


3 Medical Instruments Stocks With Potential to Outperform

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

Date : 08/09/2022

Shockwave Medical (SWAV) Up 6.1% Since Last Earnings Report: Can It Continue?

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock?

Date : 07/09/2022

Want to Beat Alphabet Stock? Buy These 2 Winners of the Bear Market

They're both soaring thanks to a handful of recent catalysts.

Date : 04/09/2022

Top 5 Momentum Stocks to Brace for a Scary September

We have narrowed our search to five large-cap momentum stocks that have solid upside left for September. These are: SWAV, PCTY, DINO, MPC and ULTA.

Date : 01/09/2022

Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences

SANTA CLARA, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat time for the Wells Fargo Healthcare Conference has been updated. The correct presentation time is 9:10 am Eastern Time. The details for the Morgan Stanley Healthcare Conference remain the same.

Date : 31/08/2022





About ShockWave Medical, Inc.


CEO : Mr. Douglas Godshall
Sector : Healthcare
Industry : Medical Devices

Website : https://www.shockwavemedical.com

Exchange : NASDAQ Global Select

Description :

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.


My Newsletter

Sign Up For Updates & Newsletters